Frieder Müller-Uri Selected Research

3- (2- (1- amantadine)- 1- one- ethylamine)digitoxigenin

2/2017	A new semisynthetic cardenolide analog 3β-[2-(1-amantadine)- 1-on-ethylamine]-digitoxigenin (AMANTADIG) affects G2/M cell cycle arrest and miRNA expression profiles and enhances proapoptotic survivin-2B expression in renal cell carcinoma cell lines.
10/2015	The New Semisynthetic Cardenolide Analog 3β-[2-(1-Amantadine)-1-on-ethylamine]-digitoxigenin (AMANTADIG) Efficiently Suppresses Cell Growth in Human Leukemia and Urological Tumor Cell Lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frieder Müller-Uri Research Topics

Disease

4	Neoplasms (Cancer) 02/2017 - 09/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2017 - 10/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2017
1	Urologic Neoplasms (Urological Cancer) 10/2015
1	Leukemia 10/2015
1	Prostatic Neoplasms (Prostate Cancer) 10/2015
1	Type 1 Spherocytosis 02/2006

Drug/Important Bio-Agent (IBA)

2	ethylamineIBA 02/2017 - 10/2015
2	3- (2- (1- amantadine)- 1- one- ethylamine)digitoxigeninIBA 02/2017 - 10/2015
2	Amantadine (Aman)FDA LinkGeneric 02/2017 - 10/2015
2	CardenolidesIBA 02/2017 - 10/2015
2	DigitoxigeninIBA 02/2017 - 10/2015
2	Digitoxin FDA Link 02/2017 - 10/2015
2	Vincristine (Oncovin)FDA LinkGeneric 01/2015 - 09/2014
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2015 - 09/2014
2	Secologanin Tryptamine Alkaloids (Alseroxylon)FDA Link 01/2015 - 09/2014
1	MicroRNAs (MicroRNA)IBA 02/2017
1	Cardiac GlycosidesIBA 02/2017
1	galantide (M 15)IBA 02/2006

Therapy/Procedure

1	Therapeutics 10/2015